Stem cell biotech MoglinBio secures seed investment
KIZOO Technology Ventures - 26-Oct-2022Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity
Join the club for FREE to access the whole archive and other member benefits.
Managing Director of Kizoo Technology Capital
Frank led the IPO of web.de, co-founded the Kizoo Venture Capital business together with Michael Greve and Matthias Hornberger, and since then helped numerous startups to grow. Among Frank’s other board-level assignments mostly at Kizoo portfolio companies, like Underdog Pharmaceuticals and Cellvie Inc., he is on the executive board of Atevia AG, a public company for 16 years, Chief Operating Officer of the Forever Healthy Foundation and co-founder of the Undoing Aging conference.
Previously, he was a strategy consultant with PriceWaterhouseCoopers. Frank holds a M.Sc. (New York) and a diploma in Business Administration and Engineering from Karlsruhe Institute of Technology (KIT), Germany.
Visit website: https://kizoo.com/#Schueler
See also: KIZOO Technology Ventures - Company providing financing and its focus is on rejuvenation biotech
Details last updated 07-Apr-2022
Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity
Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications